Literature DB >> 31473909

Candida albicans Infection Model in Zebrafish (Danio rerio) for Screening Anticandidal Drugs.

D C M Kulatunga1, S H S Dananjaya1, Chamilani Nikapitiya1, Cheol-Hee Kim2, Jehee Lee3, Mahanama De Zoysa4.   

Abstract

BACKGROUND: Candida albicans is an opportunistic fungal pathogen which causes systemic infections in human. In this study, C. albicans infection model was developed in zebrafish to understand the host-pathogen interactions for straightforward anticandidal drug screening.
METHODS: To develop the infection, 1 × 106 cells of C. albicans suspended in phosphate-buffered saline were deposited in zebrafish dorsal muscle by manually operated syringe. The infection progression was externally assessed by a scale of wound-healing events, based on visible changes of yeast deposited in the muscle tissues. Chemotherapy was carried out with known antifungal drugs (fluconazole, nystatin, and amphotericin B) and a potential antifungal agent, chitosan silver nanocomposites (CAgNC), after the infection as direct exposure in the water. Histopathological analysis was performed to identify the pathogen virulence and the host-pathogen interaction during the infection.
RESULTS: The light microscopic observations and histopathological analysis revealed the yeast-hyphae transition at the site of infection (at 72 hpi) and progression of the infection in the host tissues. The larval survival rate under fluconazole (up to 80 μg mL-1) and nystatin (up to 20 μg mL-1) was > 90% and for CAgNC it was 40% at 36 h post-exposure (hpe). The infection progression was suppressed with the fungicidal treatments. Among inflammatory genes, il-1β has been highly upregulated (14.68-fold) at 24 h post infection (hpi). Both il-1β and tnf-α were moderately upregulated in infected fish gills at 72 hpi. Among the C. albicans antioxidant genes, cat1 and sod2 have been upregulated during the infection, and relative expression folds were increased from low to moderate levels with the time. DISCUSSION: We demonstrate the approach for the development of artificial infection model of zebrafish with C. albicans. By this mini vertebrate zebrafish model, researchers will be able to study novel anticandidal compounds in vivo with respect to the host, pathogen, and their interactions.

Entities:  

Keywords:  Antifungal drugs; Candida albicans; Chitosan silver nanocomposites; Zebrafish model

Mesh:

Substances:

Year:  2019        PMID: 31473909     DOI: 10.1007/s11046-019-00378-z

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  39 in total

Review 1.  In vivo drug discovery in the zebrafish.

Authors:  Leonard I Zon; Randall T Peterson
Journal:  Nat Rev Drug Discov       Date:  2005-01       Impact factor: 84.694

Review 2.  Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options.

Authors:  J C O Sardi; L Scorzoni; T Bernardi; A M Fusco-Almeida; M J S Mendes Giannini
Journal:  J Med Microbiol       Date:  2012-11-22       Impact factor: 2.472

3.  Stress-induced gene expression in Candida albicans: absence of a general stress response.

Authors:  Brice Enjalbert; André Nantel; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.

Authors:  Y H Samaranayake; L P Samaranayake; E H Pow; V T Beena; K W Yeung
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

5.  Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.

Authors:  Alieke G Vonk; Mihai G Netea; Johan H van Krieken; Yoichiro Iwakura; Jos W M van der Meer; Bart Jan Kullberg
Journal:  J Infect Dis       Date:  2006-04-04       Impact factor: 5.226

6.  Systemic and localized infection by Candida species in patients with rheumatic diseases receiving anti-TNF therapy.

Authors:  Nadia E Aikawa; Daniela T A Rosa; Gilda M B Del Negro; Julio C B Moraes; Ana C M Ribeiro; Carla Gonçalves Saad; Clovis A Silva; Eloisa Bonfá
Journal:  Rev Bras Reumatol Engl Ed       Date:  2015-09-08

Review 7.  Immunology and zebrafish: spawning new models of human disease.

Authors:  Nathan D Meeker; Nikolaus S Trede
Journal:  Dev Comp Immunol       Date:  2008-01-07       Impact factor: 3.636

Review 8.  Invertebrate models of fungal infection.

Authors:  Marios Arvanitis; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Biochim Biophys Acta       Date:  2013-03-19

Review 9.  Host pathogen relations: exploring animal models for fungal pathogens.

Authors:  Catherine G Harwood; Reeta P Rao
Journal:  Pathogens       Date:  2014-06-30

Review 10.  Candida albicans pathogenicity mechanisms.

Authors:  François L Mayer; Duncan Wilson; Bernhard Hube
Journal:  Virulence       Date:  2013-01-09       Impact factor: 5.882

View more
  1 in total

Review 1.  Many ways, one microorganism: Several approaches to study Malassezia in interactions with model hosts.

Authors:  Kevin Ehemann; María Juliana Mantilla; Felipe Mora-Restrepo; Andrea Rios-Navarro; Maritza Torres; Adriana Marcela Celis Ramírez
Journal:  PLoS Pathog       Date:  2022-09-08       Impact factor: 7.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.